Login to Your Account



View from the Molecular Level

Combination Drug Approach Aimed at Cancer's Network

By Jennifer Boggs


Monday, November 10, 2008
SAN FRANCISCO - Over the last several years - really starting with the 1998 approval of Herceptin as the first successful targeted therapy to hit the market - cancer has become a more treatable disease. Even so, most of the achievements have come in the form of small disease progression-free increments and limited response rates.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription